BAY-1214784
- Generic Name
- BAY-1214784
First in Human Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1214784
Phase 1
Completed
- Conditions
- Clinical Trials, Phase I as Topic
- Interventions
- Drug: Placebo
- First Posted Date
- 2014-08-08
- Last Posted Date
- 2015-03-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 48
- Registration Number
- NCT02212080
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath